Jan Ohlig Selected Research

etiron

1/2014

Depletion of circulating blood NOS3 increases severity of myocardial infarction and left ventricular dysfunction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jan Ohlig Research Topics

Disease

2	Cardiotoxicity 01/2019 - 01/2018
1	Inflammation (Inflammations) 01/2019
1	Heart Failure 01/2018
1	Atrioventricular Block 10/2015
1	Cicatrix (Scar) 01/2015
1	Infarction (Infarctions) 01/2014
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2014

Drug/Important Bio-Agent (IBA)

2	AnthracyclinesIBA 01/2019 - 01/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 01/2018
1	Atrial Natriuretic Factor (ANF)IBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2018
1	NSC 23766IBA 01/2018
1	Lovastatin (Mevacor)FDA LinkGeneric 01/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018
1	Collagen Type I (Type I Collagen)IBA 01/2015
1	CollagenIBA 01/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2014
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2014
1	etironIBA 01/2014

Therapy/Procedure

1	Therapeutics 01/2019
1	Transcatheter Aortic Valve Replacement 10/2015
1	Catheters 01/2015